DUBLIN--(BUSINESS WIRE)--The "Excipients in Pharmaceuticals: Global Markets to 2022" report has been added to ResearchAndMarkets.com's offering.
This report on the pharmaceutical excipient market covers an overview of excipients, classification of excipients, and their significance in the pharmaceutical industry. The report includes market size estimates for 2016 as the base year, 2017, and forecast estimates for 2022.
A detailed analysis illustrating market dynamics, market structure analysis incorporating Porter's Five Force Framework analysis and supply chain and distribution is discussed in detail. Emerging pharmaceutical excipients such as co-processed and multifunctional excipients and their impact on the future of pharmaceutical excipients market is also analyzed.
Based on the type of material, the pharmaceutical excipient market is segmented into organic excipients, inorganic excipients and USP Water.
Based on route of administration, the pharmaceutical excipient market is segmented by-oral, injectable/parenteral, topical and advanced delivery systems.
By dosage forms, the pharmaceutical excipients market is segmented as solid dosage forms, liquid dosage forms, semi-solid dosage forms, and others (e.g., aerosol and powder).
By end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract formulators and others (e.g., academics and pharmacies).
A detailed competitive analysis of key leading pharmaceutical excipient suppliers is provided, detailing business operations and segment focus.
- Detailed analyses of organic and inorganic excipients
- Discussion of various excipient interactions, including drug-excipient interaction, excipient-excipient interaction, and package-excipient interaction
- Insight into the most critical issues surrounding excipients, including technological, regulatory, economic, and political
- Company profiles of major players in the market, including Ashland Global Holdings Inc., Cargill Inc, Meggle Pharma GmbH, The Lubrizol Corporation and Omya AG
Key Topics Covered
2 Summary and Highlights
3 Circulating Tumor Cells
4 Incidence of Cancer
6 Circulating Tumor Cells and Cancer Diagnostics
7 CTCs in Clinical Trials
8 Circulating Tumor Cell Market
9 Patents Overview
10 Selected Company Profiles
- Advanced Cell Diagnostics
- Aviva Biosciences
- Biocep Ltd.
- Biocept Inc.
- Biofluidica Microtechnologies LLC
- Canopus Biosciences
- Cellmax Life
- Celltrafix Inc.
- Clearbridge Biomedics
- Creatv Microtech Inc
- Cynvenio Biosystems Inc.
- Epic Biosciences
- Fluxion Biosciences
- Greiner Bio-One GmbH
- Ikonisys Inc.
- IVDiagnostics Inc
- Janssen Diagnostics
- Menarini-Silicon Biosystems
- Miltenyi Biotec
- Nanostring Technologies Inc.
- Natural Nano Inc.
- Stemcell Technologies
- Synergex Corp.
- Sysmex Corp.
- Vitatex Inc.
For more information about this report visit https://www.researchandmarkets.com/research/45pw28/excipients_in?w=4